TWA
USNA icon

TCI Wealth Advisors’s Usana Health Sciences USNA Stock Holding History

TCI Wealth Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-219
Closed -$13.8K – 2134
2023
Q1 		$13.8K Buy
219
+32
+17% +$1.91K ﹤0.01% 895
2022
Q4 		$9.95K Sell
187
-5
-3% -$271 ﹤0.01% 1069
2022
Q3 		$11K Buy
192
+154
+405% +$10.2K ﹤0.01% 976
2022
Q2 		$3K Buy
38
+18
+90% +$1.34K ﹤0.01% 1911
2022
Q1 		$2K Sell
20
-53
-73% -$4.78K ﹤0.01% 2036
2021
Q4 		$7K Sell
73
-14
-16% -$1.4K ﹤0.01% 1465
2021
Q3 		$8K Buy
87
+46
+112% +$4.43K ﹤0.01% 1304
2021
Q2 		$4K Hold
41
– – ﹤0.01% 1643
2021
Q1 		$4K Buy
41
+21
+105% +$1.91K ﹤0.01% 1431
2020
Q4 		$2K Sell
20
-5
-20% -$387 ﹤0.01% 1286
2020
Q3 		$2K Sell
25
-28
-53% -$2.25K ﹤0.01% 1194
2020
Q2 		$4K Buy
53
+5
+10% +$392 ﹤0.01% 845
2020
Q1 		$3K Buy
+48
New +$3.34K ﹤0.01% 930

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCI Wealth Advisors's USNA Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Usana Health Sciences (USNA) in Q2 2023, closing a stake of 219 shares — an estimated $13.8K sold.

TCI Wealth Advisors first reported a position in USNA in Q1 2020 and held it in 13 quarters. The position peaked at $13.8K in Q1 2023. 169 funds tracked by Wall St. Rank hold USNA as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Usana Health Sciences position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 219 Usana Health Sciences shares in Q2 2023, an estimated $13.8K.
  • TCI Wealth Advisors first reported a position in Usana Health Sciences in Q1 2020 and held it in 13 quarters.
  • TCI Wealth Advisors's Usana Health Sciences position peaked at $13.8K in Q1 2023.
  • 169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.